A phase I trial of ADS-4101 for the treatment of partial onset epileptic seizures in healthy volunteers
Phase of Trial: Phase I
Latest Information Update: 02 Nov 2017
At a glance
- Drugs ADS 4101 (Primary) ; Lacosamide (Primary)
- Indications Epilepsy
- Focus Adverse reactions; Pharmacokinetics
- 02 Nov 2017 According to an Adamas Pharmaceuticals media release, data will be presented at the American Epilepsy Society Annual Meeting in December 2017.
- 22 May 2017 Results published in an Adamas Pharmaceuticals media release.
- 22 May 2017 According to an Adamas Pharmaceuticals media release, positive data from the Phase 1a trial will be presented at the 14th Antiepileptic Drug and Device Trials Conference.